News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vioxx Maker Settles False Advertising Suit



9/16/2013 7:08:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Almost a decade after the maker of rofecoxib (Vioxx) pulled the once-blockbuster pain killer from the market, the company settled a class action suit charging it with overselling the benefits of the Cox-2 inhibitor. It was Merck that pulled Vioxx from drugstore shelves on Sept. 30, 2004, but it was Merck Sharp & Dohme that settled this latest suit in the U.S. District Court for the Eastern District of Louisiana for $23 million, which will come to about $50 for each patient included in the class. That settlement is a pittance compared with the settlement in the first Vioxx case -- $253 million awarded by a jury to the family of man who died in his sleep after taking the drug for 8 months.

Help employers find you! Check out all the jobs and post your resume.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES